BURLINGAME, Calif.
Our news can be accessed here on: Genomeweb Preferred Medicine News Aug 05, 2021
Preferred Medicine, a Burlingame, California-based joint venture of two Japanese firms, has begun a multicenter trial to further validate its microRNA-based blood test for the early detection of breast cancer.
Originally posted on Aug 5, 2021
About Preferred Medicine
Preferred Medicine, Inc. is a science-driven U.S. joint venture between Preferred Networks America, Inc. and Mitsui & Co., Ltd. The company was formed in November 2018 with the goal to commercialize biomedical and healthcare solutions using machine learning and deep learning technologies. Preferred Medicine is currently developing a non-invasive liquid biopsy product focused on women with a high risk for breast cancer.
Preferred Medicine is headquartered in Burlingame, California.
Media contacts:
Preferred Medicine Inc. : Info@preferred-medicine.com
Sign up to be the first to hear any updates
